DNLI icon

Denali Therapeutics

Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$29
37% upside
High target

3 analyst ratings

positive
neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside
Date
Wolfe Research
Wolfe Research
Rudy Li
24 Feb ‘26 5 days ago
BTIG
BTIG
Thomas Shrader
50% 1-yr DNLI win rate
6 Feb ‘26 24 days ago
UBS
UBS
Michael Yee
100% 1-yr DNLI win rate
7 Jan ‘26 1 month ago
Wedbush
Wedbush
Laura Chico
67% 1-yr DNLI win rate
11 Dec ‘25 2 months ago